ARTICLE | Clinical News
Kynamro mipomersen regulatory update
March 11, 2013 7:00 AM UTC
Isis disclosed in its 2012 earnings that Sanofi's Genzyme Corp. unit submitted a request for a reexamination of a December negative opinion from EMA's CHMP for an MAA for Kynamro mipomersen to treat ...